Physician profile
Angela Yu
NPI 1811127459
$1,181.70
in general payments reported to CMS, 2019-2025
13 companies · $237 in 2025
The $237 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $140 · 2021: $287 · 2022: $61.32 · 2023: $137 · 2024: $124 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $499.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $286.76 | 2021 | |
| Organon LLC | $237.41 | 2025 | Jada System |
| Caldera Medical, INC | $232.48 | 2020-2023 | Desara |
| Janssen Pharmaceuticals, INC | $124.37 | 2024 | Xarelto |
| Axonics, INC. | $80.49 | 2022-2023 | Axonics |
| Abbvie INC. | $79.72 | 2019 | |
| Acessa Health INC. | $27.55 | 2019 | |
| Medtronic USA, INC. | $25.65 | 2020 | |
| Vertical Pharmaceuticals, LLC | $20.25 | 2019 | |
| Merck Sharp & Dohme LLC | $19.32 | 2019 | |
| Emd Serono, INC. | $16.24 | 2019 | |
| Coopersurgical, INC. | $16.20 | 2019 | |
| Duchesnay USA Incorporated | $15.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.